Mich. Panel: Gilead Immune From Recalled COVID Drug Suit

Mich. Panel: Gilead Immune From Recalled COVID Drug Suit <https://www.law360.com/health/articles/2323143?nl_pk=0f5983ea-0173-4e74-85e2-7daeb9cfc0fc&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2025-04-10&read_main=1&nlsidx=0&nlaidx=8> By Carolyn Muyskens Gilead Sciences Inc. has escaped a lawsuit pinning a man's strokes on doses of an antiviral COVID-19 medication that were later recalled, with a Michigan state appeals court finding that the company is protected by a public health law's liability shield. Opinion attached | Read full article » <https://www.law360.com/health/articles/2323143?nl_pk=0f5983ea-0173-4e74-85e2-7daeb9cfc0fc&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2025-04-10&read_more=1&nlsidx=0&nlaidx=8> | Save to favorites » <https://www.law360.com/health/articles/2323143?nl_pk=0f5983ea-0173-4e74-85e2-7daeb9cfc0fc&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2025-04-10&read_later=1&nlsidx=0&nlaidx=8>
participants (1)
-
Gunnar Larson